Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis

M. Bellocchia (Orbassano, Italy), G. Bonizzoni (Orbassano, Italy), C. Biglia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), V. Difino (Orbassano, Italy), F. Traversa (Orbassano, Italy), S. Demichelis (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy)

Source: International Congress 2018 – Cystic fibrosis in adults: current research
Session: Cystic fibrosis in adults: current research
Session type: Thematic Poster
Number: 1323
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Bellocchia (Orbassano, Italy), G. Bonizzoni (Orbassano, Italy), C. Biglia (Orbassano, Italy), C. Bena (Orbassano, Italy), E. Clivati (Orbassano, Italy), V. Difino (Orbassano, Italy), F. Traversa (Orbassano, Italy), S. Demichelis (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy), C. Albera (Orbassano, Italy), B. Messore (Orbassano, Italy). Real-life experience of Omalizumab in adult Cystic Fibrosis patients with allergic severe asthma and Allergic Bronchopulmonary Aspergillosis. 1323

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: